Bittium Oyj (BITTI) Fair Value & Analysis
Technology · FI · Market cap €1.4B
Fair value as of: Jun 24, 2026
Analysis
Bittium Oyj (BITTI) currently trades at €32.25, while our model-based Fair Value estimate is €7.52 — implying the stock looks roughly 76.7% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Bittium Oyj provides communications and connectivity solutions under the Bittium brand in Finland, the rest of Europe, the Americas, and Asia. It operates through Defense & Security, Medical, and Engineering Services segments. The company offers Faros, an ECG monitor for early detection of cardiac abnormalities; OmegaSnap, a wearable disposable patch electrode for long-term ECG measurements; Cardiac Navigator, a software solution for analyzing clinical Holter ECG recordings; MedicalSuite, a cloud-based software-as-a-service solution for data sharing and management; Respiro, a recording device for nocturnal polygraph examinations; BrainStatus, a wireless and compact EEG amplifier for continuous EEG measurements in intensive care units; and NeurOne, an EEG/ERP device. It also provides Tough Mobile, Tough Mobile 2, and Tough Mobile 2 Tactical smartphones; Secure Suite, a device management and encryption software; Secure Call, a communication application; SafeMove Mobile VPN; SafeMove A…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Bittium Oyj (BITTI) undervalued?
What is the fair value of BITTI?
What is the quality score of BITTI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.